Peripheral artery disease is characterized by the build of plaque in arteries carrying blood form heart to legs, arms, and other limbs. Peripheral artery disease also increases the risk of other peripheral disorders such as heart attack, coronary heart disease, stroke, and ischemic attack.
Allied Market Research published a report, titled, “Peripheral Artery Disease Market by Type (Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Peripheral Accessories): Global Opportunity Analysis and Industry Forecast, 2020โ2027.” According to the report, the Peripheral Artery Disease Market size surpassed USD 3.52 billion in 2019 and is estimated to grow at USD 5.71 billion by 2027, registering a CAGR of 8.5% from 2020 to 2027
The report provides an extensive analysis of changing market dynamics, major segments, value chain, competitive scenario, and regional landscape. This research offers a valuable guidance to leading players, investors, shareholders, and startups in devising strategies for sustainable growth and gaining competitive edge in the market.
๐๐จ๐ฏ๐ข๐-๐๐ ๐๐๐๐ง๐๐ซ๐ข๐จ
โข Many health governing bodies have circulated guidelines regarding operating PDA during the Covid-19 pandemic. The American College of Surgeons (ACS) released guidelines for triage of vascular surgery patients. These guidelines suggest that non-emergency peripheral vascular procedures should be postponed.
โข In many regions that have been affected considerably by the pandemic, government directives or hospital guidelines have restricted vascular procedures to life or limb salvaging cases only.
โข “Production interruptions of PAD devices and delays in procedures from hospitals due to COVID-19 pandemic is expected to effect the growth of Peripheral Artery Disease Market.”
๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐ซ๐๐ฉ๐ก๐ฌ ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ ๐๐๐ซ๐:
https://www.alliedmarketresearch.com/request-sample/4315
๐๐ก๐๐ญ ๐๐ซ๐ ๐ญ๐ก๐ ๐๐๐๐ญ๐จ๐ซ๐ฌ ๐๐ซ๐ข๐ฏ๐ข๐ง๐ ๐ญ๐ก๐ ๐๐๐ซ๐ข๐ฉ๐ก๐๐ซ๐๐ฅ ๐๐ซ๐ญ๐๐ซ๐ฒ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐๐๐ซ๐ค๐๐ญ?
Emergence of advanced interventional products, enhanced healthcare infrastructure in developing nations, and supportive insurance and reimbursement policies drive the growth of the global peripheral artery disease market. However, strict approval process for stents hinders the market growth. On the other hand, untapped potential in developing nations create new opportunities in the coming years.
๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ ๐จ๐ ๐๐ฅ๐จ๐๐๐ฅ ๐๐๐ซ๐ข๐ฉ๐ก๐๐ซ๐๐ฅ ๐๐ซ๐ญ๐๐ซ๐ฒ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ –
โข Abbott Laboratories
โข Boston Scientific Corporation
โข Cook Medical
โข Cardinal Health, Inc.
โข Becton, Dickinson and Company
โข Terumo Corporation
โข Koninklijke Philips N.V
โข AngioDynamics, Inc.
โข BIOTRONIK
โข B. Braun Melsungen AG
๐๐ฅ๐จ๐๐๐ฅ ๐๐๐ซ๐ข๐ฉ๐ก๐๐ซ๐๐ฅ ๐๐ซ๐ญ๐๐ซ๐ฒ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง –
Based on type, the peripheral stents segment contributed to the largest market share, holding nearly two-fifths of the total share of the global peripheral artery disease market in 2019, and is expected to maintain its highest contribution during the forecast period. This is attributed to technological innovations leading to development of bio-engineered stents, dual therapy stents, and EPC capture stents. However, the plaque modification devices segment is expected to grow at the largest CAGR of 9.5% from 2020 to 2027. This is due to necessity of these devices while ballooning of arteries fail.
Based on region, North America accounted for the highest share in terms of revenue, contributing to nearly two-fifths of the global peripheral artery disease market in 2019, and will maintain its lead position during the forecast period. This is due to changes in lifestyle habits such as unhealthy dietary habits, smoking, excessive alcohol consumption, and lack of physical activity of people in the region. However, Asia-Pacific is expected to grow at the highest CAGR of 9.4% from 2020 to 2027, owing to expansion of healthcare budgets, rise in disposable income, and surge in demand for technologically advanced devices.
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.alliedmarketresearch.com/purchase-enquiry/4315
Our Market Research Solution Provides You Answer to Below Mentioned Question:
- Which are the driving factors responsible for the growth of market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are main factors responsible for new product launch?
- How big is the global & regional market in terms of revenue, sales and production?
- How far will the market grow in forecast period in terms of revenue, sales and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
- Which region has more opportunities?
By Region Outlook
โข North America
(U.S., Canada, Mexico)
โข Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
โข Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
โข LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.